𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combined inhibitory effect of formestane and herceptin on a subpopulation of CD44+/CD24low breast cancer cells

✍ Scribed by Carla Cavaliere; Sara Corvigno; Mario Galgani; Gennaro Limite; Agostina Nardone; Bianca Maria Veneziani


Book ID
108586756
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
443 KB
Volume
101
Category
Article
ISSN
1347-9032

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Molecular mechanisms underlying IGF-I-in
✍ Yuhong Lu; Xiaolin Zi; Michael Pollak πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 450 KB

## Abstract The clinical usefulness of trastuzumab (Herceptin; Genentech, San Francisco, CA) in breast cancer treatment is limited by the rapid development of resistance. We previously reported that IGF‐I signaling confers resistance to the growth‐inhibitory actions of trastuzumab in a model system